Skip to main content

Table 5 Five-year OS and 5-year DFS for patients in different groups

From: Prognostic analysis of patients with stage IIIC1p cervical cancer treated by surgery

Variables

5-year OS

5-year DFS

Postoperative treatment

 None

10.0%

10.0%

 Chemotherapy

50.0%

47.5%

 Chemo plus radiotherapy

86.5%

84.6%

LNR

  ≤ 0.3

76.9%

75.6%

  > 0.3

25.0%

20.8%

NLR

  ≤ 3.8

70.5%

69.3%

  > 3.8

28.6%

21.4%

Surgical method

 Laparoscope

63.4%

62.2%

 Laparotomy

70.0%

65.0%

  1. LNR Lymph node ratio, NLR Neutrophil–lymphocyte ratio, OS Overall survival, DFS Disease-free survival